MYC and neoplasm: The results demonstrated that pathways associated with tumor progression, such as glycolysis, Myc targets, E2F targets, angiogenesis, the epithelial–mesenchymal transition (EMT), the G2M checkpoint, and the hedgehog signaling pathway, were mainly enriched in the high‐risk group of patients with ESCA (Supplementary Figure S3).